| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $839.0M | $805.9M | $835.6M |
| YoY Revenue Growth % | +4.1% | -3.6% | — |
| Gross Profit | $271.2M | $252.3M | — |
| Gross Margin % | 32.3% | 31.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $66.0M | $81.8M | $79.9M |
| Operating Margin % | 7.9% | 10.2% | 9.6% |
| Net Income (GAAP) | $48.4M | $39.0M | $37.5M |
| EBITDA (Normalized) | $85.0M | $103.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $127.3M | $122.1M | $83.9M |
| Capital Expenditures (CapEx) | $23.7M | $27.0M | — |
| Free Cash Flow (FCF) | $103.6M | $95.1M | $83.9M |
| FCF Margin % | 12.3% | 11.8% | 10.0% |
| Return on Invested Capital (ROIC %) | 4.7% | 5.9% | — |
| Cash & Short-Term Equivalents | $73.0M | $44.1M | — |
| Total Debt (Short + Long Term) | $256.2M | $283.2M | — |
| Total Stockholders' Equity | $931.5M | $864.4M | — |